Search Within

Department of Medicine

Formats
  1. Journal Article (19579)
  2. Meeting Abstract (16038)
  3. Review (1149)
  4. Book Section (934)
  5. Editorial (607)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (235)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22314)
  2. Hematologic Malignancies, Division of (13268)
  3. Center for Hematologic Malignancies (11053)
  4. GSK Faculty (10642)
  5. Survivorship Research (9326)
  6. Division of Subspecialty Medicine (7533)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1068)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1052)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3721)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6457)
  2. Elsevier Inc. (4215)
  3. American Society of Hematology (4000)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2110)

More Publishers

Results (39603)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PYNNACLE phase II assessing rezatapopt in patients with advanced solid tumors, including lung cancer, harboring a TP53 Y220C mutation
    Meeting Abstract

    De Miguel, M. J.; Dumbrava, E. E.; Body, A.; Eberst, L.; Frenel, J. S.; Italiano, A.; Johnson, M. L.; Kaczmar, J.; Kummar, S.; Lorusso, P. M.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Co-occurrence of PI3K pathway gene alterations in endometrial cancer molecular subtypes at the single cell level
    Meeting Abstract

    Da Cruz Paula, A.; Zhu, Y.; Brown, D.; Pareja, F.; de Oliveira, T. B.; Dopeso, H.; da Silva, E. M.; Chandarlapaty, S.; Abu-Rustum, N.; Reis, J.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Correlation of NECTIN4 amplification and expression with response to enfortumab vedotin (EV) treatment in locally advanced or metastatic urothelial carcinoma
    Meeting Abstract

    Yol, C.; Irawan, H.; Sternschuss, M.; Gupta, A.; Bent, E.; Basar, M.; Chen, J. F.; Sarungbam, J.; Chen, Y. B.; Gopalan, A.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Histopathological and molecular characterization of POLE/POLD1-mutant colorectal carcinomas
    Meeting Abstract

    Caires, D.; Moher, C.; Shia, J.; Vakiani, E.; Bahceci, D.; Urganci, N.; Firat, C.; Stadler, Z.; Weiser, M.; Garcia-Aguilar, J.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Does longitudinal NGS testing provide clinically relevant information in translocation associated sarcomas (TAS)?
    Meeting Abstract

    Yakoub, M.; Saoud, C.; Tap, W.; Wexler, L.; Hameed, M.; Antonescu, C.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Germline genetic alterations in homologous recombination deficiency/DNA damage response genes in breast cancer
    Meeting Abstract

    Keske, A.; Terraf, P.; Gazzo, A.; Repetto, M.; Schwartz, C.; Ross, D.; Zhang, H.; Chandarlapaty, S.; Wen, H.; Brogi, E.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • What is the clinical impact of secondary genetic alterations (SGA) in translocation associated sarcomas (TAS)?
    Meeting Abstract

    Chang, H. Y.; Tap, W.; Hameed, M.; Vanderbilt, C.; Antonescu, C.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Immunohistochemical staining for RAS Q61R mutation in B-cell lymphoproliferative disorders identifies mutated subclones
    Meeting Abstract

    Isgor, I.; Liu, Y.; Lopez, K.; Jungbluth, A.; Serrette, R.; Dogan, A.; Chan, A.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Chemo-immunotherapy for borderline resectable and unresectable NSCLC
    Meeting Abstract

    Cappuzzo, F.; Landi, L.; Garbo, E.; Cooper, A.; Wang, X.; Mayoral, M.; Ginsberg, M. S.; Sholl, L.; Nishino, M.; Bott, M.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Phase I study of patritumab deruxtecan (HER3-DXd) in patients (pts) with advanced KRAS G12C non-small cell lung cancer (NSCLC): Study U102 cohort 5
    Meeting Abstract

    Paz-Ares, L.; Steuer, C.; Ruiter, G.; Nishio, M.; Murakami, H.; Kim, D. W.; Felip, E.; Baik, C. S.; Lin, C. C.; Massarelli, E.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save